Stocks and Investing Stocks and Investing
Fri, September 6, 2024
Thu, September 5, 2024

Ami Fadia Reiterated (AXSM) at Strong Buy and Held Target at $130 on, Sep 5th, 2024


Published on 2024-10-28 14:06:32 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $130 on, Sep 5th, 2024.

Ami has made no other calls on AXSM in the last 4 months.



There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 0 agree with Ami's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Ami


  • Cerena Chen of "Wells Fargo" Initiated at Buy and Held Target at $140 on, Tuesday, September 3rd, 2024
  • Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $105 on, Tuesday, August 6th, 2024
  • Jason Gerberry of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $106 on, Tuesday, August 6th, 2024
  • Leonid Timashev of "RBC Capital" Maintained at Buy with Decreased Target to $130 on, Tuesday, August 6th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $107 on, Friday, July 26th, 2024
  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $106 on, Wednesday, June 12th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 7th, 2024
  • Joel Beatty of "Baird" Maintained at Buy with Increased Target to $112 on, Tuesday, May 7th, 2024
Contributing Sources